Endo-Praxis 2016; 32(03): 98-102
DOI: 10.1055/s-0042-109140
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Die Grenzen der Adipositastherapie

Warum die Betroffenen oft doch nicht abnehmen
M. Reiser
Klinik für Innere Medizin II, Klinikum Vest GmbH, Paracelsus-Klinik Marl
› Author Affiliations
Further Information

Publication History

Publication Date:
17 August 2016 (online)

Die zunehmende Adipositasprävalenz ist ein weltweites Gesundheitsproblem. Konservative, medikamentöse und endoskopische Therapiestrategien sind dabei wenig erfolgreich und die bariatrische Chirurgie ist nur für einen kleinen Patientenkreis nutzbar.

 
  • Literatur

  • 1 WHO. WHO Global InfoBase. Global Comparable Estimates, Risk Factors etc. Im Internet: https://apps.who.int/infobase/ (Stand: 23.5.16)
  • 2 Branca F, Nikogosian H, Lobstein T ed. The challenge of obesity in the WHO European Region and the strategies for response: summary. Im Internet: http://www.euro.who.int/en/publications/abstracts/challenge-of-obesity-in-the-who-european-region-and-the-strategies-for-response-the.-summary (Stand: 23.5.16)
  • 3 Flegal KM, Kit BK, Orpana H et al. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71-82
  • 4 Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine 2003; 348: 1625-1638
  • 5 Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology and Metabolism 2004; 89: 2548-2556
  • 6 Apovian CM, Aronne LJ, Bessesen DH et al. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism 2015; 100: 342-362
  • 7 Bueter M, le Roux CW. Gastrointestinal hormones, energy balance and bariatric surgery. International Journal of Obesity 2011; 35: 35-S39
  • 8 Suzuki K, Jayasena CN, Bloom SR. The Gut Hormones in Appetite Regulation. Journal of Obesity 2011; 2011: 1-10
  • 9 Farooqi IS, Keogh JM, Yeo GSH et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. The New England Journal of Medicine 2003; 348: 1085-1095
  • 10 Wabitsch M, Funcke JB, Lennerz B et al. Biologically Inactive Leptin and Early-Onset Extreme Obesity. The New England Journal of Medicine 2015; 372: 48-54
  • 11 Speliotes EK, Willer CJ, Berndt SI et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 2010; 42: 937-948
  • 12 Sacks FM, Bray GA, Carey VJ et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine 2009; 360: 859-873
  • 13 Sumithran P, Prendergast LA, Delbridge E et al. Long-term persistence of hormonal adaptations to weight loss. The New England Journal of Medicine 2011; 365: 1597-1604
  • 14 Fildes A, Charlton J, Rudisill C et al. Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. Am J Public Health 2015; 105: e54-e59
  • 15 Saltiel AR. New therapeutic approaches for the treatment of obesity. Sci Transl Med 2016; 8: 1-11
  • 16 Christensen R, Kristensen PK, Bartels EM et al. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. The Lancet 2007; 370: 1706-1713
  • 17 Pi-Sunyer X, Astrup A, Fujioka K et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. The New England Journal of Medicine 2015; 373: 11-22
  • 18 Rodgers RJ, Tschöp MH, Wilding JPH. Anti-obesity drugs: past, present and future. Disease Models & Mechanisms 2012; 5: 621-626
  • 19 Chen Z, Guo L, Zhang Y et al. Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. The Journal of Clinical Investigation 2014; 124: 3391-3406
  • 20 Fernandes M, Atallah AN, Soares BGO et al. Intragastric balloon for obesity. Cochrane Database Syst Rev 2007; CD004931
  • 21 Patel SRH, Hakim D, Mason J et al. The duodenal-jejunal bypass sleeve (EndoBarrier Gastrointestinal Liner) for weight loss and treatment of type 2 diabetes. Surgery for Obesity and Related Diseases 2013; 9: 482-484
  • 22 Sullivan S, Stein R, Jonnalagadda S et al. Aspiration Therapy Leads to Weight Loss in Obese Subjects: A Pilot Study. Gastroenterology 2013; 145: 1245-1252
  • 23 Bang CS, Baik GH, Shin IS et al. Effect of intragastric injection of botulinum toxin A for the treatment of obesity: a meta-analysis and meta-regression. YMGE 2015; 81: 1141-1149
  • 24 Deutsche Adipositas Gesellschaft. Interdisziplinäre Leitlinie der Qualität S3 zur „Prävention und Therapie der Adipositas“. AWMF-Register Nr. 050/001 2014. Im Internet: http://www.adipositas-gesellschaft.de/fileadmin/PDF/Leitlinien/S3_Adipositas_Praevention_Therapie_2014.pdf (Stand: 23.5.16)
  • 25 Sandoval D. Bariatric surgeries: beyond restriction and malabsorption. International Journal of Obesity 2011; 35: 45-49
  • 26 Golomb I, Ben David M, Glass A et al. Long-term Metabolic Effects of Laparoscopic Sleeve Gastrectomy. JAMA Surg 2015; 150: 1051-1057
  • 27 Gloy VL, Briel M, Bhatt DL et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934
  • 28 Karmali S, Brar B, Shi X et al. Weight Recidivism Post-Bariatric Surgery: A Systematic Review. Obes Surg 2013; 23: 1922-1933
  • 29 Bocca G, Corpeleijn E, Stolk RP et al. Results of a Multidisciplinary Treatment Program in 3-Year-Old to 5-Year-Old Overweight or Obese Children: A Randomized Controlled Clinical Trial. Arch Pediatr Adolesc Med 2012; 166: 1109-1115
  • 30 Danielsson P, Kowalski J, Ekblom Ö et al. Response of Severely Obese Children and Adolescents to Behavioral Treatment. Arch Pediatr Adolesc Med 2012; 166: 1103-1108